Loading…
Two Medium to long duration funds side by side: returns, costs, size, risk and how much their portfolios overlap.
SBI Medium to Long Term Fund vs UTI Medium to Long Term Fund, as of 9 Nov 2026: SBI Medium to Long Term Fund NAV ₹80.73, 3Y CAGR 6.9%, expense ratio 0.78%; UTI Medium to Long Term Fund NAV ₹83.52, 3Y CAGR 6.4%, expense ratio 1.32%; about 0% of their portfolios overlap.
As of · Source: AMFI NAVs and fund-house disclosures
| SBI Medium to Long Term Fund Direct Growth | UTI Medium to Long Term Fund Direct Growth | |
|---|---|---|
| Category | Medium to long duration | Medium to long duration |
| Fund house | SBI Mutual Fund | UTI Mutual Fund |
| Plan | Direct Plan · Growth | Direct Plan · Growth |
| NAV | ₹80.73 (9 Nov 2026) | ₹83.52 (9 Nov 2026) |
| 1Y return | 4.2% | 3.1% |
| 3Y CAGR | 6.9% | 6.4% |
| 5Y CAGR | 6.2% | 6.9% |
| Since launch (CAGR) | 7.8% | 6.7% |
| Expense ratio | 0.78% | 1.32% |
| AUM | ₹2,020 cr | ₹303 cr |
| Risk-o-meter | Moderately High | Moderately High |
| Benchmark | CRISIL Medium to Long Duration Debt A-III Index | CRISIL Medium to Long Duration Debt A-III Index |
| Exit load | — | No load after 6 months |
| Minimum SIP | ₹500 | ₹500 |
| Holdings | 28 | 27 |
| Top 10 holdings weight | 65.6% | 64.9% |
| Portfolio overlap | About 0% by weight, from the latest disclosed holdings | |
Returns are point-to-point for each plan, after its expense ratio; periods over one year are CAGR. Past performance is not indicative of future results.
Open in the compare tool: growth charts, SIP outcomes and shared holdings →UTI Medium to Long Term Fund has the higher 5-year CAGR (as of 9 Nov 2026): SBI Medium to Long Term Fund 6.2% a year vs UTI Medium to Long Term Fund 6.9% a year. Past performance is not indicative of future results.
SBI Medium to Long Term Fund costs less: SBI Medium to Long Term Fund charges 0.78% a year and UTI Medium to Long Term Fund 1.32% a year.
SBI Medium to Long Term Fund is larger: SBI Medium to Long Term Fund manages ₹2,020 cr and UTI Medium to Long Term Fund ₹303 cr (as of 9 Nov 2026).
About 0% of their portfolios overlap by weight (the smaller weight of each common holding, summed), from the latest disclosed holdings.
Both are rated "Moderately High" on SEBI's risk-o-meter.
We don't give recommendations. Jivani Markets is not a SEBI-registered investment adviser or research analyst. Whether a fund suits you depends on your goals, horizon and risk appetite; speak to a SEBI-registered investment adviser or an AMFI-registered mutual fund distributor before investing.
Mutual Fund investments are subject to market risks, read all scheme related documents carefully. Past performance is not indicative of future results.
Returns are for Direct plans, after expenses (TER is already in the NAV). Research, not advice: we do not say a fund suits you. Disclaimer